Empowered Funds’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.79M	Sell	5,410 -14,021	-72%	-$4.77M	0.01%	1160
2025 Q4	$7.73M	Buy	19,431 +15,146	+353%	+$6.7M	0.13%	181
2025 Q3	$1.95M	Buy	4,285 +1,432	+50%	+$583K	0.02%	931
2025 Q2	$930K	Sell	2,853 -3,048	-52%	-$843K	0.01%	1100
2025 Q1	$1.59M	Sell	5,901 -1,729	-23%	-$444K	0.02%	839
2024 Q4	$1.8M	Buy	7,630 +566	+8%	+$149K	0.03%	779
2024 Q3	$1.94M	Buy	7,064 +5,362	+315%	+$1.4M	0.03%	686
2024 Q2	$414K	Sell	1,702 -12,147	-88%	-$1.92M	0.01%	1106
2024 Q1	$2.07M	Buy	13,849 +524	+4%	+$87.4K	0.04%	603
2023 Q4	$2.55M	Buy	13,325 +11,873	+818%	+$2.02M	0.06%	430
2023 Q3	$257K	Buy	1,452 +134	+10%	+$25.6K	0.01%	1092
2023 Q2	$250K	Sell	1,318 -17	-1%	-$3.37K	0.01%	1014
2023 Q1	$267K	Buy	+1,335	New	+$281K	0.02%	467
2022 Q4	–	Sell	-1,031	Closed	-$220K	–	449
2022 Q3	$206K	Buy	+1,031	New	+$197K	0.02%	308